<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="3959">
  <stage>Registered</stage>
  <submitdate>3/06/2013</submitdate>
  <approvaldate>3/06/2013</approvaldate>
  <nctid>NCT01870570</nctid>
  <trial_identification>
    <studytitle>Determination of Glycaemic Index and Insulinaemic Index Values of 6 Food Products in 3 Separate Research Centers</studytitle>
    <scientifictitle>Determination of Glycaemic Index and Insulinaemic Index Values of 6 Cereal Products in 3 Separate Research Centers</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>KBE019</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Glycaemia</healthcondition>
    <healthcondition>Insulinemia</healthcondition>
  </conditions>
  <interventions>
    <interventions>Other interventions - Reference Glucose
Other interventions - Food Product A: Corn Flakes
Other interventions - Food Product B: Ginger Bread
Other interventions - Food Product C:Sandwiched Breakfast Biscuit
Other interventions - Food Product D: Crackers Nature
Other interventions - Food Product E: Breakfast Biscuit
Other interventions - Food Product F: White Bread

Other: Reference Glucose - Glucose Standard (50g of Glucose)

Experimental: Food Product A: Corn Flakes - Corn Flakes

Experimental: Food Product B: Ginger Bread - Ginger Bread

Experimental: Food Product C:Sandwiched Breakfast Biscuit - Sandwiched Breakfast Biscuit

Experimental: Food Product D: Crackers Nature - Crackers Nature

Experimental: Food Product E: Breakfast Biscuit - Breakfast Biscuit

Experimental: Food Product F: White Bread - White Bread


Other interventions: Reference Glucose


Other interventions: Food Product A: Corn Flakes


Other interventions: Food Product B: Ginger Bread


Other interventions: Food Product C:Sandwiched Breakfast Biscuit


Other interventions: Food Product D: Crackers Nature


Other interventions: Food Product E: Breakfast Biscuit


Other interventions: Food Product F: White Bread


</interventions>
    <comparator />
    <control />
    <interventioncode>Other interventions interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Determine and Perform Inter-Laboratory Comparison of Glycaemic Index Values of 6 Food Products</outcome>
      <timepoint>0-120 minutes</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Determine and Perform Inter-Laboratory Comparison of Incremental Area Under the Curve (iAUC) of Glycaemia for Each of the 6 Food Products</outcome>
      <timepoint>0-120 minutes</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Determine and Perform Inter-Laboratory Comparison of the Glucose Cmax for Each of the 6 Food Products</outcome>
      <timepoint>0-120 minutes</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Determine and Perform Inter-Laboratory Comparison of the Blood Glucose Delta Peak for Each of the 6 Food Products</outcome>
      <timepoint>0-120 minutes</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Determine and Perform Inter-Laboratory Comparison of Insulinemic Index for Each of the 6 Food Products</outcome>
      <timepoint>0-120 minutes</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Determine and Perform Inter-Laboratory Comparison of the Incremental Area Under the Curve (iAUC) of Insulinemia for Each of the 6 Food Products</outcome>
      <timepoint>01-20 minutes</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Determination and Perform Inter-Laboratory Comparison of Insulin Cmax for Each of the 6 Food Products</outcome>
      <timepoint>0-120 minutes</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Determine and Perform Inter-Laboratory Comparison of the Blood Insulin Delta Peak for Each of the 6 Food Products</outcome>
      <timepoint>0-120 minutes</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Determine the Intra-Laboratory Variability for the iAUC of Glycaemia</outcome>
      <timepoint>0-120 minutes</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Determine the Intra-Laboratory Variability of the iAUC of Insulinemia</outcome>
      <timepoint>0-120 minutes</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1. Aged 18-35 years inclusive.

          2. Non-smoker.

          3. BMI 19.0-25.0 kg/m2 inclusive.

          4. Healthy subjects with:

               -  Fasting plasma glucose &lt; 5,6 mM (ADA criteria,2011)

               -  Insulin resistance index based on homeostasis model assessment (HOMA-IR) &lt;1.70

               -  Fasting lipids: triglyceride &lt;1.70mmol/L, LDL-cholesterol&lt;5.00 mmol/L and
                  HDL-cholesterol &gt;1.03mmol/L for males or &gt;1.29mmol/L for females (IDF criteria
                  for metabolic syndrome, 2006)

               -  Gamma-GT, AST and ALT &lt;1.5 times the upper limit of normal (ULN)

               -  Complete blood count: Normal full blood count according to the investigator

               -  Systolic blood pressure &lt;130 mmHg

               -  Diastolic blood pressure &lt;85 mmHg

               -  Resting heart rate 50-90 beats per minutes (after 3 minutes rest).

          5. Stable dietary habits; normal eating patterns; no history of eating disorders or
             strict dieting.

          6. Moderate level of physical activity (from basic daily activity to a high level of
             physical activity (regular physical activity at least 3 times per week))

          7. Able to fast for at least 10 hours the night before each test session.

          8. Able to refrain from eating legumes and drinking alcohol the day before each test
             session.

          9. Subject covered by social security or covered by a similar system

         10. Subject not taking any treatment for anorexia, weight loss, or any form of treatment
             likely to interfere with metabolism or dietary habits

         11. Subject having given written consent to take part in the study</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>35</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>1. Following a restrictive or specific diet.

          2. Suffering from any inflammatory or metabolic diseases

          3. Suffering from mental illness.

          4. Suffering from any food allergies or hypersensitivities (wheat, milk, egg, nuts, etc).

          5. Taking any regular prescription medication at the time of inclusion that should
             interfere with carbohydrate metabolism (except regular oral contraception medication,
             thyroid replacement therapy)

          6. Female who is pregnant (positive test results), lactating, planning pregnancy or not
             using acceptable contraceptive.

          7. Subject having taken part in another clinical trial within the last week.

          8. Subject currently taking part in another clinical trial or being in the exclusion
             period of another clinical trial.

          9. Subject undergoing general anaesthesia in the month prior to inclusion.

         10. Subject in a situation which in the investigator's opinion could interfere with
             optimal participation in the present study or could constitute a special risk for the
             subject.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Basic Science</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/06/2013</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>48</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/12/2013</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <hospital>Human Nutrition Unit, The University of Sydney - Sydney</hospital>
    <postcode>2006 - Sydney</postcode>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Ontario</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Saint Herblain</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Mondelez International, Inc.</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>BioFortis</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Commercial sector/Industry</othercollaboratortype>
      <othercollaboratorname>Glycemic Index Laboratories, Inc</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>University of Sydney</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to determine and compare the glycaemic index values and response
      parameters of 6 food products between 3 laboratories.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01870570</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>David Gendre, Dr.</name>
      <address>BioFortis</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>